Telemedicine in Movement Disorders: Leçons du COVID‐19

From the Document: This Fact Sheet informs you of the significant known and potential risks and benefits of the emergency use of the COVID-19 [coronavirus disease 2019] RT-PCR [reverse transcription polymerase chain reaction] Peptide Nucleic Acid (PNA) kit The COVID-19 RT-PCR Peptide Nucleic Acid (PNA) kit is authorized for use with respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider COVID-19 (Disease);Health--Testing;Public health surveillance;Healthcare

[1]  R. Barker,et al.  Forecasts for the Attainment of Major Research Milestones in Parkinson's Disease. , 2020, Journal of Parkinson's disease.

[2]  B. Bloem,et al.  The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders. , 2020, JAMA neurology.

[3]  B. Bloem,et al.  Telemedicine for Hyperkinetic Movement Disorders , 2020, Tremor and other hyperkinetic movements.

[4]  T. Moulin,et al.  National survey on telemedicine education and training among medical students and residents in France , 2019, European Journal of Public Health.

[5]  Paolo Bonato,et al.  A roadmap for implementation of patient‐centered digital outcome measures in Parkinson's disease obtained using mobile health technologies , 2019, Movement disorders : official journal of the Movement Disorder Society.

[6]  Judith A. Hall,et al.  Nonverbal Communication. , 2019, Annual review of psychology.

[7]  G. Stebbins,et al.  Telemedicine vs Office Visits in a Movement Disorders Clinic: Comparative Satisfaction of Physicians and Patients , 2018, Movement disorders clinical practice.

[8]  J. Vozenilek,et al.  Clinician behaviors in telehealth care delivery: a systematic review , 2017, Advances in health sciences education : theory and practice.

[9]  M. Elliott,et al.  Evaluation of telephone first approach to demand management in English general practice: observational study , 2017, British Medical Journal.

[10]  C. Tanner,et al.  Virtual visits for Parkinson disease: A multicenter noncontrolled cohort , 2017, Neurology. Clinical practice.

[11]  C. Watson,et al.  Heart Failure Virtual Consultation: bridging the gap of heart failure care in the community ‐ A mixed‐methods evaluation , 2017, ESC heart failure.

[12]  S. Wiig,et al.  Perceptions of telecare training needs in home healthcare services: a focus group study , 2017, BMC Health Services Research.

[13]  B. Bloem,et al.  Moving Parkinson care to the home , 2016, Movement disorders : official journal of the Movement Disorder Society.

[14]  Max A. Little,et al.  Technology in Parkinson's disease: Challenges and opportunities , 2016, Movement disorders : official journal of the Movement Disorder Society.

[15]  P. Barbour,et al.  Telehealth for patients with Parkinson’s disease: delivering efficient and sustainable long-term care , 2016, Hospital practice.

[16]  Janet E. Anderson,et al.  Patient safety risks associated with telecare: a systematic review and narrative synthesis of the literature , 2014, BMC Health Services Research.

[17]  N. Britten,et al.  Telephone triage for management of same-day consultation requests in general practice (the ESTEEM trial): a cluster-randomised controlled trial and cost-consequence analysis , 2014, The Lancet.

[18]  Z. Mari,et al.  The past, present, and future of telemedicine for Parkinson's disease , 2014, Movement disorders : official journal of the Movement Disorder Society.

[19]  Lauren E. Sherman,et al.  The effects of text, audio, video, and in-person communication on bonding between friends , 2013 .

[20]  Fabrizio Benedetti,et al.  Placebo and the new physiology of the doctor-patient relationship. , 2013, Physiological reviews.

[21]  Michael T. Bull,et al.  Randomized Controlled Clinical Trial of 'Virtual House Calls' for Parkinson Disease , 2013, JAMA neurology.

[22]  E. Cubo,et al.  Comparison of office‐based versus home web‐based clinical assessments for Parkinson's disease , 2012, Movement disorders : official journal of the Movement Disorder Society.

[23]  P. Mccormack,et al.  Is the Irish bedside best? , 2010, Irish journal of medical science.

[24]  Nancy Longnecker,et al.  Doctor-patient communication: a review. , 2010, The Ochsner journal.

[25]  D. Roter,et al.  An Evaluation of Patient-Physician Communication Style During Telemedicine Consultations , 2009, Journal of medical Internet research.

[26]  Glyn Lewis,et al.  The patient-doctor relationship: a synthesis of the qualitative literature on patients' perspectives. , 2009, The British journal of general practice : the journal of the Royal College of General Practitioners.

[27]  J André Knottnerus,et al.  Quality of communication during telephone triage at Dutch out-of-hours centres. , 2009, Patient education and counseling.

[28]  N. Hjelm,et al.  Benefits and drawbacks of telemedicine , 2005, Journal of telemedicine and telecare.

[29]  J. Car,et al.  Open disclosure: the only approach to medical error , 1999, Quality and Safety in Health Care.

[30]  M. Zunzunegui,et al.  Callers' ability to understand advice received from a telephone health-line service: comparison of self-reported and registered data. , 2003, Health services research.

[31]  A Jon Stoessl,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Placebos and the Placebo Effect the Placebo Effect in Neurological Disorders , 2022 .

[32]  Richard Chua,et al.  Telemedicine for new neurological outpatients: putting a randomized controlled trial in the context of everyday practice. , 2002, Journal of telemedicine and telecare.

[33]  R. Wootton,et al.  Randomised controlled trial of telemedicine for new neurological outpatient referrals , 2001, Journal of neurology, neurosurgery, and psychiatry.

[34]  M. Hensley,et al.  Student and patient perspectives on bedside teaching , 1997, Medical education.

[35]  M. Stewart Effective physician-patient communication and health outcomes: a review. , 1995, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.